Literature DB >> 16808765

Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists.

Suephy C Chen1, Michelle L Pennie, Paul Kolm, Erin M Warshaw, Eric L Weisberg, Katherine M Brown, Michael E Ming, William S Weintraub.   

Abstract

BACKGROUND: Primary care physicians (PCPs) are often expected to screen for melanomas and refer patients with suspicious pigmented lesions to dermatologists.
OBJECTIVE: To assess whether there is a difference between dermatologists and PCPs in accurately diagnosing melanoma and appropriately managing (based on decisions to refer/biopsy) suspicious pigmented lesions. DESIGN, PARTICIPANTS: A survey based on a random sample of 30 photographs of pigmented lesions with known pathology was administered to 101 dermatologists and 115 PCPs from October 2001 to January 2003. MEASUREMENTS: Likelihoods that a photographed lesion was melanoma and that the lesion should be biopsied/referred were scored on a 1 to 10 scale. Accuracy of melanoma diagnosis and appropriateness of pigmented lesion management were compared between dermatologists and PCPs by using the areas under (AUC) the receiver operating characteristic (ROC) curves.
RESULTS: Dermatologists were superior to PCPs in diagnosing melanomas (AUC 0.89 vs 0.80, P<.001) and appropriately managing pigmented lesions (AUC .84 vs 0.76, P<.001). PCPs who tended to biopsy lesions themselves did better at managing pigmented lesions than PCPs who did not perform biopsies. Dermatology training during residency did not significantly improve the diagnostic accuracy of PCPs nor their management of pigmented lesions.
CONCLUSIONS: Dermatologists have both better diagnostic accuracy and ability to manage pigmented lesions than PCPs. Yet, there is a shortage of dermatologists to meet the demand of accurate melanoma screening. More innovative strategies are needed to better train PCPs and enhance skin cancer screening.

Entities:  

Mesh:

Year:  2006        PMID: 16808765      PMCID: PMC1924688          DOI: 10.1111/j.1525-1497.2006.00462.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  23 in total

Review 1.  Genetic testing in hereditary melanoma.

Authors:  Hensin Tsao; Kristin Niendorf
Journal:  J Am Acad Dermatol       Date:  2004-11       Impact factor: 11.527

2.  Clinical dermatologic education and the diagnostic acumen of medical students and primary care residents.

Authors:  D L Whitaker-Worth; W S Susser; J M Grant-Kels
Journal:  Int J Dermatol       Date:  1998-11       Impact factor: 2.736

Review 3.  Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now?

Authors:  R Marks
Journal:  Australas J Dermatol       Date:  1999-02       Impact factor: 2.875

4.  Quality of care: issue or oversight in health care reform?

Authors:  B A Solomon; R Collins; N B Silverberg; A T Glass
Journal:  J Am Acad Dermatol       Date:  1996-04       Impact factor: 11.527

5.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

6.  The recognition and management of melanoma and other skin lesions by general practitioners in New Zealand.

Authors:  R McGee; M Elwood; H Adam; M J Sneyd; S Williams; M Tilyard
Journal:  N Z Med J       Date:  1994-07-27

7.  General practitioner screening for melanoma: sensitivity, specificity, and effect of training.

Authors:  R C Burton; C Howe; L Adamson; A L Reid; P Hersey; A Watson; G Watt; J Relic; D Holt; V Thursfield; P Clarke; B K Armstrong
Journal:  J Med Screen       Date:  1998       Impact factor: 2.136

8.  Skin cancer control practices among physicians in a university general medicine practice.

Authors:  N C Dolan; G J Martin; J K Robinson; A W Rademaker
Journal:  J Gen Intern Med       Date:  1995-09       Impact factor: 5.128

9.  A comparison of diagnosis, evaluation, and treatment of patients with dermatologic disorders.

Authors:  D Federman; D Hogan; J R Taylor; P Caralis; R S Kirsner
Journal:  J Am Acad Dermatol       Date:  1995-05       Impact factor: 11.527

10.  Primary care physicians as gatekeepers in managed care. Primary care physicians' and dermatologists' skills at secondary prevention of skin cancer.

Authors:  B Gerbert; T Maurer; T Berger; S Pantilat; S J McPhee; M Wolff; A Bronstone; N Caspers
Journal:  Arch Dermatol       Date:  1996-09
View more
  36 in total

1.  Melanoma: is more diagnosis better?

Authors:  Marianne Berwick
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

2.  Please, sir, pull down your socks!

Authors:  D Bonucchi; J Piattoni; F Ravera; A M Savazzi; G Cappelli; N Pimpinelli; P A Modesti
Journal:  Intern Emerg Med       Date:  2007-12       Impact factor: 3.397

Review 3.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

4.  The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.

Authors:  Richard G Roetzheim; Ji-Hyun Lee; Jeanne M Ferrante; Eduardo C Gonzalez; Ren Chen; Kate J Fisher; Kymia Love-Jackson; Ellen P McCarthy
Journal:  J Am Board Fam Med       Date:  2013 Nov-Dec       Impact factor: 2.657

5.  Current biopsy practices for suspected melanoma: A survey of family physicians in Southwestern Ontario.

Authors:  Kristina Lutz; Victoria Hayward; Mariamma Joseph; Eric Wong; Claire Temple-Oberle
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

6.  Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy.

Authors:  Laura K Ferris; Burkhard Jansen; Jonhan Ho; Klaus J Busam; Kenneth Gross; Doyle D Hansen; John P Alsobrook; Zuxu Yao; Gary L Peck; Pedram Gerami
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

7.  Understanding visual search patterns of dermatologists assessing pigmented skin lesions before and after online training.

Authors:  Elizabeth A Krupinski; Joseph Chao; Rainer Hofmann-Wellenhof; Lynne Morrison; Clara Curiel-Lewandrowski
Journal:  J Digit Imaging       Date:  2014-12       Impact factor: 4.056

8.  Cosmetic light therapies and the risks of atypical pigmented lesions.

Authors:  Lauren Curry; Natalie Cunningham; Shweta Dhawan
Journal:  Can Fam Physician       Date:  2021-06       Impact factor: 3.275

9.  Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States.

Authors:  Elliot J Coups; Alan C Geller; Martin A Weinstock; Carolyn J Heckman; Sharon L Manne
Journal:  Am J Med       Date:  2010-05       Impact factor: 4.965

10.  Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].

Authors:  Fiona M Walter; Helen C Morris; Elka Humphrys; Per N Hall; Ann Louise Kinmonth; A Toby Prevost; Edward Cf Wilson; Nigel Burrows; Paul Norris; Margaret Johnson; Jon Emery
Journal:  BMC Fam Pract       Date:  2010-05-11       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.